IMNN

$0.00

(

0.00%

)
Quote details

stock

Imunon Inc

NASDAQ | IMNN

6.70

USD

0.00

(

0.00%

)

AT CLOSE (AS OF Aug 13, 2025)

$17M

MARKET CAP

-

P/E Ratio

-12.93

EPS

$41

52 Week High

$4.8

52 Week Low

LIFE SCIENCES

Sector

IMNN Chart

Recent Chart
Price Action
1D
Candles

Trade Smarter

Automate your trading workflow with powerful tools — built for serious traders.

Icon For Time-schedule

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Icon For Search

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Icon For Clipboard-list

Journal

Record your trades and performance to improve your trading with AfterPullback's Trading Journal

IMNN Technicals

Tags:

IMNN Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$718K
Total Revenue $0
Cost Of Revenue $718K
Costof Goods And Services Sold $718K
Operating Income -$19M
Selling General And Administrative $7.5M
Research And Development $12M
Operating Expenses $19M
Investment Income Net -
Net Interest Income $450K
Interest Income $450K
Interest Expense $0
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $718K
Income Before Tax -$19M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$19M
Comprehensive Income Net Of Tax -
Ebit -$19M
Ebitda -$18M
Net Income -$19M

Revenue & Profitability

Earnings Performance

IMNN Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $9.7M
Total Current Assets $8M
Cash And Cash Equivalents At Carrying Value $5.9M
Cash And Short Term Investments $5.9M
Inventory -
Current Net Receivables -
Total Non Current Assets $1.7M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $0
Other Current Assets $2.1M
Other Non Current Assets -
Total Liabilities $5.5M
Total Current Liabilities $4.8M
Current Accounts Payable $1.3M
Deferred Revenue -
Current Debt -
Short Term Debt $452K
Total Non Current Liabilities $687K
Capital Lease Obligations $1.1M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.1M
Other Current Liabilities $3M
Other Non Current Liabilities -
Total Shareholder Equity $4.2M
Treasury Stock -
Retained Earnings -$407M
Common Stock $145K
Common Stock Shares Outstanding $972K

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$19M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $718K
Capital Expenditures $30K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $9.8M
Cashflow From Financing $9.1M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$19M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$718K
Total Revenue $0
Cost Of Revenue $718K
Costof Goods And Services Sold $718K
Operating Income -$19M
Selling General And Administrative $7.5M
Research And Development $12M
Operating Expenses $19M
Investment Income Net -
Net Interest Income $450K
Interest Income $450K
Interest Expense $0
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $718K
Income Before Tax -$19M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$19M
Comprehensive Income Net Of Tax -
Ebit -$19M
Ebitda -$18M
Net Income -$19M

IMNN News

IMNN Profile

Imunon Inc Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

None

Discover more tools and features to empower your trading
Explore Features

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.